BeStock  
Stocks › Biotechnology › TSHA

Taysha Gene Therapies TSHA

US equityMarket cap rank #3032Biotechnology
$3.72 −$0.05 (-1.33%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $3.71 -0.27%
Open$3.67
Prev close$3.77
Day range$3.60 – $3.80
Volume3.15M
Market cap$1.21B
P/E (TTM)–
Dividend yield–

Earnings

Average move on report day±19.7%last 16 reports
Closed higher10 of 1663% of the time
Best reaction+188.2%
Worst reaction-6.2%

Stock move on the day after each report

+31.6%2023/Q4+21.0%2024/Q1-2.4%2024/Q2+2.7%2024/Q3-4.7%2024/Q4+8.0%2025/Q1+5.4%2025/Q2-4.3%2025/Q3+2.5%2025/Q4+0.6%2026/Q1+4.9%2026/Q2-1.6%2026/Q3
QuarterReport dateTimingImplied moveActual moveVersus implied
2026/Q312 Nov 2026Pre Market±20.0%-1.64%Within range
2026/Q211 Aug 2026None±16.5%+4.87%Within range
2026/Q16 May 2026Pre Market±16.9%+0.58%Within range
2025/Q419 Mar 2026Pre Market±18.2%+2.47%Within range
2025/Q34 Nov 2025None±25.8%-4.26%Within range
2025/Q212 Aug 2025Pre Market±27.4%+5.43%Within range
2025/Q115 May 2025Pre Market±39.5%+8.02%Within range
2024/Q426 Feb 2025Pre Market±50.8%-4.71%Within range
2024/Q313 Nov 2024After Market±30.3%+2.71%Within range
2024/Q212 Aug 2024Pre Market±33.5%-2.39%Within range
2024/Q114 May 2024After Market±28.4%+21.01%Within range
2023/Q419 Mar 2024After Market±45.2%+31.56%Within range
2023/Q314 Nov 2023After Market±41.9%+26.32%Within range
2023/Q214 Aug 2023Pre Market–+188.23%–
2023/Q111 May 2023None±240.0%-5.47%Within range
2022/Q428 Mar 2023Pre Market±253.2%-6.19%Within range

"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.

Latest reported quarter: Q2, ended Jun 2026

Revenue$0.00-100.0% YoY
Operating profit-$50.78M-89.8% YoY
Net profit-$46.64M-73.5% YoY
Diluted EPS-$0.13-44.4% YoY
Free cash flow-$40.42M-100.3% YoY
Operating cash flow-$40.43M

Revenue, last 8 quarters

$1.8MSep '24$2.0MDec '24$2.3MMar '25$2.0MJun '25$0.0Sep '25$5.5MDec '25$0.0Mar '26$0.0Jun '26

Net profit, last 8 quarters

$-25.5MSep '24$-18.8MDec '24$-21.5MMar '25$-26.9MJun '25$-32.7MSep '25$-27.9MDec '25$-42.4MMar '26$-46.6MJun '26

Profitability & balance sheet

Operating margin-2,854.9%
Net margin-2,728.0%
Return on equity-47.1%
Return on assets-37.2%
Return on invested capital-42.7%
Current ratio17.76
Liabilities / assets17.7%
Cash & investments$455.41M
Total debt$55.55M
Net cash (debt)$399.86M

Discussion

No comments yet — be the first to weigh in on TSHA.

Sign in to join the discussion.

Scroll to Top